Kidney Transplant Stocks List Ranked for 2024 |

	Symbol	Grade	Name	% Change
	HOOK	F	HOOKIPA Pharma Inc.	-6.52
	BMY	B	Bristol-Myers Squibb Company	1.10

Related Industries: Biotechnology Drug Manufacturers - Major

Symbol	Grade	Name	Weight
FTXH	C	First Trust Nasdaq Pharmaceuticals ETF	8.89
MEDX	F	Horizon Kinetics Medical ETF	6.23
PPH	D	Market Vectors Pharmaceutical ETF	5.89
MVAL	A	SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF	5.37
RDIV	A	RevenueShares Ultra Dividend Fund	5.27

Compare ETFs

Date	Stock	Title
Nov 22	BMY	AbbVie Jumps Nearly 4% On An Upgrade Despite Bristol Myers-Tied Setback
Nov 22	HOOK	Hookipa Pharma price target lowered to $7 from $24 at JMP Securities
Nov 22	HOOK	Hookipa Pharma announces workforce reduction of 80%, pause of eseba-vec program
Nov 21	BMY	Major companies that are also popular short-selling stocks
Nov 21	BMY	Is Bristol Myers Squibb Stock a Buy?
Nov 21	BMY	Want Over $3,000 in Annual Dividends? Invest $20,000 in Each of These 3 Stocks
Nov 19	BMY	Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript)
Nov 19	BMY	Bristol Myers Squibb’s Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms
Nov 18	BMY	Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
Nov 18	BMY	Is Bristol-Myers Squibb Company (BMY) the Best Immunotherapy Stock to Buy Now?
Nov 18	BMY	EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer
Nov 17	BMY	Bristol-Myers Squibb: Buy This Bargain Before It's Gone
Nov 17	HOOK	Companies Like HOOKIPA Pharma (NASDAQ:HOOK) Could Be Quite Risky
Nov 17	HOOK	HOOKIPA Pharma Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Nov 17	BMY	Large Pension Doubled Palantir Stake, Bought Up Intel and CVS Stock

Kidney Transplant: Kidney transplantation or renal transplantation is the organ transplant of a kidney into a patient with end-stage renal disease. Kidney transplantation is typically classified as deceased-donor (formerly known as cadaveric) or living-donor transplantation depending on the source of the donor organ.
Living-donor renal transplants are further characterized as genetically related (living-related) or non-related (living-unrelated) transplants, depending on whether a biological relationship exists between the donor and recipient.
Exchanges and chains are a novel approach to expand the living donor pool. In February 2012, this novel approach to expand the living donor pool resulted in the largest chain in the world, involving 60 participants organized by the National Kidney Registry. In 2014 the record for the largest chain was broken again by a swap involving 70 participants.